Basal cell carcinoma: A Nationwide clinicopathologic study in an Israeli population Basal cell cancer distribution

Main Article Content

Ariel Berl
Ofir Shir-az https://orcid.org/0000-0001-7942-6394
Gilad Winder https://orcid.org/0000-0001-9629-9403
Manar Kawar https://orcid.org/0000-0002-3677-0897
Prof. Avshalom Shalom https://orcid.org/0000-0003-2074-1650

Keywords

Basal cell carcinoma, Skin neoplasms, Epidemiology, Healthcare delivery, Risk factors

Abstract

Background: Basal cell carcinoma (BCC) is the most common malignancy worldwide, with a continuously increasing incidence. BCC occurs mostly on areas of the body subject to chronic sun exposure in older people.


Aim: To characterize the anatomical distribution and properties of BCC in a nationwide sample in Israel.


Methods: This retrospective study included histologically confirmed BCC samples obtained from surgeons throughout Israel during the first trimester of 2012.


Results: A total of 1,716 BCC lesions were diagnosed during the study period. The head and neck had the highest density of BCC (65.9%). The mean lesion horizontal diameter was larger in males than in females (0.91 cm vs. 0.8 cm; P<0.001). Male sex and older age were risk factors for lesion ulceration.


Conclusions: According to our population-based study, males of older ages are at increased risk of developing larger and ulcerated BCC lesions. The head and neck are the most affected areas. With increasing age, the frequency of upper limb BCC increases in males and on the lower limbs in females. Increased frequency of evaluations in at-risk groups such as males of older age with an emphasis on high-risk areas of the body, is recommended.

Abstract 180 | PDF Downloads 57

References

1. Nguyen T, Ho D. Nonmelanoma skin cancer. Curr Treat Options Oncol. 2002;3(3):193-203. doi:10.1007/s11864-002-0009-0.
2. American Cancer Society. Cancer facts and figures. Published 2023. https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/2023-cancer-facts-figures.html (last accessed 28 March 2023).
3. International Agency for Research on Cancer. Global Cancer Observatory: Cancer Today. Lyon, France. Published 2020. https://gco.iarc.fr/today/fact-sheets-cancers (last accessed 28 March 2023).
4. Apalla Z, Lallas A, Sotiriou E, Lazaridou E, Ioannides D. Epidemiological trends in skin cancer. Dermatol Pr Concept. 2017;7(2):1-6. doi:10.5826/dpc.0702a01.
5. Cameron M, Lee E, Hibler B, Barker CA, Mori S, Cordova M, Nehal KS, Rossi AM. Basal cell carcinoma. Epidemiology; pathophysiology; clinical and histological subtypes; and disease associations. J Am Acad Dermatol. 2019;80:303-317.
6. Lear J, Smith A. Basal cell carcinoma. Postgr Med J. 1997;73(863):538-542. doi:10.1136/pgmj.73.863.538.
7. Youssef K, Van Keymeulen A, Lapouge G, Beck B, Michaux C, Achouri Y, Sotiropoulou PA, Blanpain C. Identification of the cell lineage at the origin of basal cell carcinoma. Nat Cell Biol. 2010;12(3):299-305.
8. Puig S, Berrocal A. Management of high-risk and advanced basal cell carcinoma. Clin Transl Oncol. 2015;17(7):497-503.
9. Leffell D, Headington J, Wong D, Swanson N. Aggressive-growth basal cell carcinoma in young adults. Arch Dermatol. 1991;127(11):1663-1667.
10. Lo J, Snow S, Reizner G, Mohs F, Larson P, Hruza G. Metastatic basal cell carcinoma: report of twelve cases with a review of the literature. Am Acad Dermatol. 1991;24(5 Pt 1):715-719. doi:10.1016/0190-9622(91)70108-e.
11. Madan V, Hoban P, Strange R, Fryer A, Lear J. Genetics and risk factors for basal cell carcinoma. Br J Dermatol. 2006;154(Suppl 1):5-7. doi:10.1111/j.1365-2133.2006.07229.x.
12. Heath M, Bar A. Basal Cell Carcinoma. Dermatol Clin. 2023;41(1):13-21. doi:10.1016/j.det.2022.07.005
13. Gallagher R, Lee T. Adverse effects of ultraviolet radiation: A brief review. Prog Biophys Mol Biol. 2006;92(1):119-131. doi:10.1016/j.pbiomolbio.2006.02.011.
14. Corona R, Dogliotti E, D’Errico M, Sera F, Iavarone I, Baliva G, Chinni LM, Gobello T, Mazzanti C, Puddu P, Pasquini P. Risk factors for basal cell carcinoma in a Mediterranean population: role of recreational sun exposure early in life. Arch Dermatol. 2001;137(9):1162-1168. doi:10.1001/archderm.137.9.1162.
15. Roewert-Huber J, Lange-Asschenfeldt B, Stockfleth E, Kerl H. Epidemiology and aetiology of basal cell carcinoma. Br J Dermatol. 2007;157(Suppl 2):47-51. doi:10.1111/j.1365-2133.2007.08273.x.
16. Swanbeck G, Hillström L. Analysis of etiological factors of squamous cell skin cancer of different locations. Acta Derm Venereol. 1971;51(2):151-156.
17. Almaani N, Juweid M, Alduraidi H, Ganem N, Abu-Tayeh FA, Alrawi R, Hawwari T. Incidence Trends of Melanoma and Nonmelanoma Skin Cancers in Jordan From 2000 to 2016. JCO Glob Oncol. 2023;e2200338. doi:10.1200/GO.22.00338
18. Sexton M, Jones D, Maloney M. Histologic pattern analysis of basal cell carcinoma. Study of a series of 1039 consecutive neoplasms. J Am Acad Dermatol. 1990;23(6 Pt 1):1118-1126. doi:10.1016/0190-9622(90)70344-h.
19. Koyuncuer A. Histopathological evaluation of non-melanoma skin cancer. World J Surg Oncol. 2014;12(159). doi:10.1186/1477-7819-12-159.
20. Zargaran M, Moghimbeigi A, Monsef A, Teimourian H, Shojaei S. A clinicopathological survey of Basal cell carcinoma in an Iranian population. J Dent (Shiraz). 2013;14(4):170-177.
21. Qureshi A, Qureshi H, Singla R, Gill M. Audit of 100 consecutive basal cell carcinoma specimens at a secondary care centre in the UK. J Pak Med Assoc. 2023;73(3):572-574. doi:10.47391/JPMA.6502
22. Tan ES, Ee M, Shen L, Chua H, Chan Y-H, Tan S-H. Basal cell carcinoma in Singapore: a prospective study on epidemiology and clinicopathological characteristics with a secondary comparative analysis between Singaporean Chinese and Caucasian patients. Australas J Dermatol. 2015;56(3):175-179. doi:10.1111/ajd.12202.
23. Tiftikcioglu YO, Karaaslan O, Aksoy HM, Aksoy B, Kocer U. Basal cell carcinoma in Turkey. J Derm. 2006;33(2):91-95. doi: 10.1111/j.1346-8138.2006.00019.x
24. Bastiaens M, Hoefnagel J, Bruijn J, Westendorp RG, Vermeer BJ, Bouwes Bavinck JN. Differences in age, site distribution, and sex between nodular and superficial basal cell carcinoma indicate different types of tumors. J Invest Dermatol. 1998;110(6):880-884. doi:10.1046/j.1523-1747.1998.00217.x.
25. McCormack C, Kelly J, Dorevitch A. Differences in age and body site distribution of the histological subtypes of basal cell carcinoma. A possible indicator of differing causes. Arch Dermatol. 1997;133(5):593-596.
26. Scrivener Y, Grosshans E, Cribier B. Variations of basal cell carcinomas according to gender, age, location and histopathological subtype. Br J Dermatol. 2002;147(1):41-47. doi:10.1046/j.1365-2133.2002.04804.x.
27. Bellenghi M, Puglisi R, Pontecorvi G, De Feo A, Carè A, Mattia G. Sex and Gender Disparities in Melanoma. Cancers (Basel). 2020;12(7):1819. doi:10.3390/cancers12071819.
28. Swetter S, Layton C, Johnson T, Brooks K, Miller D, Geller A. Gender differences in melanoma awareness and detection practices between middle-aged and older men with melanoma and their female spouses. Arch Dermatol. 2009;145(4):488-490. doi:10.1001/archdermatol.2009.42.
29. Rubegni P, Rossi S, Nami N, Risulo M, Biagioli M, Miracco C, Fimiani M. A single centre melanoma thickness trend (1985-2009) in relation to skin areas accessible and non-accessible to self-inspection. Australas J Dermatol. 2012;53(1):32-36. doi:10.1111/j.1440-0960.2011.00835.x.